TORONTO –
Well being Canada has approved Moderna’s up to date COVID-19 vaccine that protects towards at present circulating variants of the virus.
The mRNA vaccine, referred to as Spikevax, has been reformulated to focus on the KP.2 subvariant of Omicron.
It’s going to exchange the earlier model of the vaccine that was launched a yr in the past, which focused the XBB.1.5 subvariant of Omicron.
Well being Canada just lately requested provinces and territories to do away with their older COVID-19 vaccines to make sure essentially the most present vaccine might be used throughout this fall’s respiratory virus season.
Well being Canada can also be reviewing two different up to date COVID-19 vaccines however has not but approved them.
They’re Pfizer’s Comirnaty, which can also be an mRNA vaccine, in addition to Novavax’s protein-based vaccine.
This report by The Canadian Press was first revealed Sept. 17, 2024.
Canadian Press well being protection receives help by a partnership with the Canadian Medical Affiliation. CP is solely chargeable for this content material.